Kenmotsu H. Combination of Osimertinib and Vascular Endothelial Growth Factor Receptor Inhibitors for EGFR-Mutated Non-Small Cell Lung Cancer: Old or New Regimen? J Clin Oncol 2024 Oct 11:JCO2401921. doi: 10.1200/JCO-24-01921.
PMID: 39393033